S&P, Nasdaq Set to Snap Losing Streaks as Dow Lags

Apple, meanwhile, has swung lower

Emma Duncan

Managing Editor

Sep 10, 2018 at 12:13 PM

U.S. stocks are mixed at midday, with the Dow Jones Industrial Average (DJI) modestly lower after Apple (AAPL) stock erased its earlier gains. This comes after BofA-Merrill Lynch suggested iPhone prices could rise 20% should production move back to the U.S., as suggested in a weekend tweet from President Donald Trump, and is offsetting impressive gains from a handful of blue-chips such as Nike (NKE) and Home Depot (HD). However, the Nasdaq Composite (IXIC) and S&P 500 Index (SPX) are higher, on track to end a four-session losing streak.

Continue reading for more on today's market, including:

One analyst is targeting nearly 200% upside for this retail stock.
The Dow stock plunging on an analyst downgrade.
Plus, VFC's call options surge; Eros International lands licensing deal; and the plunging biotech.

Midday Chart Sept 10

The North Face parent VF Corp (NYSE:VFC) is sporting unusual options volume today, ahead of the company's Vans Brand investor meeting this Wednesday, Sept. 12. VFC is up 0.7% at $90.08, with roughly 8,000 calls -- compared to fewer than 350 puts --- on the tape so far, seven times the average intraday pace.The September 90.50 and 92.50 calls are most active, due to what could possibly be the initiation of a call ratio spread. On the charts, VFC has picked up nearly 22% year-to-date.

One of the top stocks on the New York Stock Exchange (NYSE) today is Eros International Plc (NYSE:EROS), after the entertainment production company announced a licensing deal with Chinese video streaming service iQiyi (IQ). EROS has gapped 5.4% higher to trade at $11.65, recovering slightly from Friday's four-month low of $10.55. Eros stock has shed over 21% from its late-June peak, and is just below breakeven year-over-year.

One stock sitting near the bottom of the Nasdaq today is Acorda Therapeutics Inc (NASDAQ:ACOR), after the biotech's appeal to revive its Ampyra patents was denied. The stock has plunged 15.9% to $23.18, trading back below its 320-day trendline for the first time since late April. But despite falling 29% over the past three months, ACOR stock continues to cling onto an 8% year-to-date gain.

Daily Chart of ACOR with 320 MA

Follow @Schaeffers

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?